WashingtonUS drug regulator’s advisers voted 7-2 that Galleri’s benefits outweigh risks.

Galleri, made by Grail, is a blood test designed to screen for multiple types of cancer.

The panel voted 10-0 that the test is safe but only 6-4 that it is effective.

The agency is not obliged to follow its panels, but it often does.

How each outlet framed it
STAT
highlights unanimous safety vote (10-0) while effectiveness narrowly split (6-4), shows guarded FDA approval

Sources: STAT